NAF Pharma – Your Expert Partner In Advanced Therapies Logistics Solution

Cell and gene therapy's next chapter will be written in Asia, especially China, outperforming the rest of the word by 4% year-on-year.

Bio companies are pouring millions upon millions into advancing cell and gene therapies on the frontier. But how good are these breakthroughs if the cell & gene therapy cant’t reach patients securely and intact?

Let NAF Pharma overcome these immense logistics hurdles.

The New Supply Chain Model For Cell & Gene Therapy (Vein-To-Vein)

Tristique enim imperdiet non malesuada quam eget quis consequat et malesuada tellus accumsan risus morbi enim donec eget adipiscing suspendisse. Tristique enim imperdiet non malesuada quam eget quis consequat et malesuada tellus accumsan risus morbi enim donec eget adipiscing suspendisse.

Tristique enim imperdiet non malesuada quam eget quis consequat et malesuada tellus accumsan risus morbi enim donec eget adipiscing suspendisse. Tristique enim imperdiet non malesuada quam eget quis consequat et malesuada tellus accumsan risus morbi enim donec eget adipiscing suspendisse.

Tristique enim imperdiet non malesuada quam eget quis consequat et malesuada tellus accumsan risus morbi enim donec eget adipiscing suspendisse. Tristique enim imperdiet non malesuada quam.

One significant challenge in cell and gene therapies is the viability of starting material, such as blood, human tissue, and organs, which are highly sensitive to time and temperature.

Patient's cells leave their vein as raw material. But will that transformed therapy survive the journey back?

Temperature fluctuations. Customs delays. Handling errors. There’s no room for mistakes. 

Our dry shippers can maintain sub-zero temperatures for days using dry ice or liquid nitrogen refilling systems. SmartLog real-time monitoring detects fluctuations before they threaten your therapy's integrity.

We treat each cell delivery like a life depends on it - because it truly does.

Heading

Pulvinar tempor sed eget dolor. Auctor faucibus duis in enim, amet maecenas sit nam.

SOLUTION

Maintaining Ultra-Low Temperatures with Dry Shippers

Your living therapy’s shelf life can be brutally short, but NAF's revolutionary dry ice shipping solutions make sure it will survive the trip. 

Our advanced dry shipper uses liquid nitrogen to maintain ultra-low (-70ºC) temperatures for up to 3 weeks without refills,even under extreme conditions.

Seamless 4-step handling, open, load, ship, and unload. No stressing about damage from mishandling. 

Protect your cell & gene therapies with NAF’s cutting-edge dry shipper solutions.

Quis quam turpis eu aliquam nisi felis nullam eget erat.
Quis sit sem volutpat ut dolor morbi non semper.
Ut libero pellentesque ornare ornare et purus.
Facilisis dignissim sit mattis sem.
SOLUTION

End-to-End Visibility for Seamless Cell & Gene Therapy Transport

NAF Pharma puts real-time visibility into your cell & gene therapy supply chain.

Smart data loggers integrated alongside your therapy shipments.

Monitor locations in real-time. 

Log temperature data at each step. 

Alert instantly if critical intervention is required.

Maximum Cell Viability

Maximum Cell Viability

Safeguard your therapies and maintain their vitality from start to finish.

Risk Based Approach

Risk-Based Approach

Strict and detailed planning procedures with a risk-based approach to ensure safety, security and integrity.

Validated and Certified Processes

Validated and Certified Processes

NAF Pharma adheres to validated SOPs and GDP-certified processes to meet the stringent handling requirements.

Cryogenic Liquid Nitrogen

Qualified Packaging Systems

Utilize active and passive packaging solutions to secure delicate therapies throughout transportation.

Real Time Tracking

Real-Time Tracking Capabilities 

Shipments with smart sensors and GPS to provide real-time location and condition data for complete visibility.

Pharma Logistics Experts

Cell and Gene Therapy Expertise

Experts from distinguished pharmaceutical and biotech background with over 16+ years of experience.

FAQs

Frequently asked questions

Answers to the burning questions in your mind.

Can't find answer?
Drop us an email
How does NAF Pharma ensure the safety and viability of cell and gene therapies during transport?

Our process includes using validated and qualified packaging systems to ensure that your product is safely transported from one place to another, while our tracking systems provide real-time visibility of the transport chain.

What qualifications does NAF Pharma have to handle cell and gene therapy logistics?

NAF Pharma is the first and only GDP-compliant cold chain logistics provider in Hong Kong. We are accredited with various international quality standards and certifications, such as ISO 9001:2015 and ISO45001 (Soon in April).

NAF Pharma is recognized as the Best Pharma Partner in Asia in 2022 at the MiPharma Logistics Conference 2022.

What kind of risks can occur during cell and gene therapy transport, and how does NAF Pharma mitigate those risks?

Risks during cell and gene therapy transport include exposure to ambient temperatures as well as vibration, shock or other mechanical damage.

To mitigate these risks, NAF Pharma utilizes a combination of tertiary packaging systems and high-performance thermal packaging, along with validated and qualified packaging systems. We also offer validation services to help customers ensure that their packaging

Does NAF Pharma monitor and track cell and gene therapies during transport? How can I access the data?

Your therapies are being watched and recorded throughout the whole journey with our real-time trackers and GPS systems.

The log data is available via our customer portal, from which you can access and view directly or download it to your desktop for future use.

The Gold Standard in Cell & Gene Therapy Logistics

NAF Pharma’s decades of expertise have guided countless life-saving therapies to patients worldwide.

Trust only the experts in this field when it comes down to life because your therapy's journey shouldn't be left to chance.